Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

DISC-GMCSF completes phase I study

June 20, 2002

Product R cleared for phase I solid tumor trial

June 19, 2002

CpG-7909 enters phase I/II in malignant melanoma

June 17, 2002

G17DT plus chemotherapy gives encouraging results in metastatic stomach cancer

June 14, 2002

Product R cleared for Israeli phase I study in leukemia and lymphoma

June 14, 2002

Pharmexa updates AutoVac HER-2 DNA pharmaccine trial progress

June 13, 2002

Medarex and IDM partner to develop Cell Drugs in combination with MDX-010

June 13, 2002

KW-2871 enters malignant melanoma study

June 13, 2002

GVAX cancer vaccines highlighted at the ASGT meeting

June 12, 2002

ING-1 suitable for further evaluation according to initial human study

June 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...